Jennifer Brown, MD
Psychiatry · Cambridge, MANPI 1578600763
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $36,890 of the $37,115 with a category attached, or 99.4%. 5 manufacturers reported payments, led by AbbVie at 36.2% of the total. Among psychiatry clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 17 payments — averaging $2183.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$13K
- Astrazeneca UK Limited$13K
- Janssen Global Services, LLC$9K
- AstraZeneca$1K
- Pharmacyclics LLC, An Abbvie Company$363
Across 33 payments — averaging $23,419 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beigene, Ltd.$677K
- Bristol Myers Squibb$93K
- Pharmacyclics LLC, An Abbvie Company$4K
What the payments were for
- Consulting fees$36,89099%
- Travel & lodging$2251%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $13,454 |
| Astrazeneca UK Limited | 7 | $13,199 |
| Janssen Global Services, LLC | 1 | $9,100 |
| AstraZeneca | 1 | $1,000 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $363 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$37,115 in reported general payments places this provider in the 95th percentile of 1,431 psychiatry providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Cambridge
- Craig SurmanCambridge$111K
- Theresa CerulliNorth Andover$724K
- Andrew AldridgeMedford$407K
- Amjad BahnassiWorcester$352K
- Ximena Sanchez-SamperBoston$258K
- Robert AlexanderBelmont$170K
- George PapakostasBoston$170K
- Xiangyang LiMilford$166K
- Ernesto ZilberbergNorth Andover$141K
- Maurizio FavaBoston$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.